Skip to content

Home
About
- Investor Relations
- Our Team
SEAL™
HealthCare Professionals
Patients
- MRI safety information
Contact

Home
About
- Investor Relations
- Our Team
SEAL™
HealthCare Professionals
Patients
- MRI safety information
Contact

Home
About
Seal™
Patients
HealthCare Professionals

Healthcare Professionals - Instructions for Use

Country

Language

Paper copy

Contact@gtseal.com

Pre-Clinical Data

Flow Study SEAL VS WEB: SVIN 2021
Animal Data Study Matt Gounis: SNIS 2020
Animal Aneurysm Elastase Model Comparing SEAL Arc to WEB Device

Clinical Data

First SEAL Clinical Publication in INR 2023
SNIS SEAL Early Feasibility Clinical Study 33 Aneurysms (2023)
SVIN SEAL Early Feasibility Clinical Study 26 Aneurysms (2022)

European Union: The SEAL™ Embolization System is CE marked under Regulation (EU) 2017/745. Product availability is subject to applicable local requirements.

United States: CAUTION: Investigational device. Limited by Federal (U.S.) law to investigational use only.

Refer to the applicable Instructions for Use for indications, contraindications, warnings, precautions, and device sizing information.

Galaxy Therapeutics, INC.
803 Ames Avenue
Milpitas, CA 95035
Email: Contact@gtseal.com

Privacy policy
Terms of Use